* Japanese*
Asahikawa Medical College , Faculty of Medicine
1991.03 , Graduated
Asahikawa Medical College , Graduate School, Division of Medicine
Doctor Course , 1995.03 , Completed
Duty , Asahikawa Medical University School of Medicine Medical Course Basic Medicine Pathology[Immuno Pathology] , Professor , 2011.07 -
English: Nagato T, Komatsuda H, Hayashi R, Takahara M, Ujiie N, Kosaka A, Ohkuri T, Oikawa K, Sato R, Wakisaka R, Kono M, Yamaki H, Ohara K, Kumai T, Kishibe K, Katada A, Hayashi T, Kobayashi H., Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma. , Cancer Sci. , 2024 , (IF:5.7)
English: Murai A, Kubo T, Ohkuri T, Yanagawa J, Yajima Y, Kosaka A, Li D, Nagato T, Murata K, Kanaseki T, Tsukahara T, Nagasaki T, Hirohashi Y, Kobayashi H, Torigoe T., NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein. , Immunol Med. , 2024 , (IF:4.4)
English: Yajima Y, Kosaka A, Ohkuri T, Hirohashi Y, Li D, Nagasaki T, Nagato T, Torigoe T, Kobayashi H., SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity. , Heliyon , vol.9 (9) (p.e20192 - ) , 2023 , (IF:4)
English: Yamaki H, Kono M, Wakisaka R, Komatsuda H, Kumai T, Hayashi R, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Hayashi T, Kobayashi H, Katada A., Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer. , Cancer Immunol Immunother. , vol.72 (8) (p.2799 - 2812) , 2023 , (IF:5.8)
English: Nagato T, Komatsuda H, Hayashi R, Takahara M, Kishibe K, Yasuda S, Yajima Y, Kosaka A, Ohkuri T, Oikawa K, Harabuchi S, Kono M, Yamaki H, Wakisaka R, Hirata- Nozaki Y, Ohara K, Kumai T, Katada A, Hayashi T, Harabuchi Y, Kobayashi H., Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy. , Cancer Immunol Immunother. , vol.27 (2) (p.2087 - 2098) , 2023 , (IF:6.630)
Japanese: DNA methylation-driven repressin of tumor antigen , CLINICAL ONCOLOGY , vol.27 (5) (p.552 - 557) , 2021
Japanese: Stealth tumor antigen , Clinical Immunology & Allergoloogy , vol.75 (5) (p.539 - 543) , 2021
The International Conference: American Association for Cancer Research Annual Meeting , 2018.04
The International Conference: AAI Annual Meeting IMMUNOLOGY 2014 , 2014.05
The International Conference: AAI Annual Meeting IMMUNOLOGY 2014 , 2014.05
The International Conference: American Association of Cancer Research Annual Meeting 2014 , 2014.04
The International Conference: American Association of Cancer Research Annual Meeting 2013 , 2013.04
Partner division:Others , 2012.04 - 2016.03
Updated on 2024/02/17
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.